Navigation Links
FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
Date:4/3/2012

ood test on the market that accurately predicts the risk of near term (2-3 years) myocardial infarction or death in patients with suspected or confirmed, insignificant or significant coronary artery disease. Research has discovered that there are multiple pathways that lead to formation of vulnerable plaques. PREvent aggregates three cardiovascular biomarkers that identify these pathways, and projects the propensity for an individual to develop vulnerable plaque. PREvent provides physician's diagnostic clarity in identifying CAD patients that are in most urgent need of aggressive treatment, compliance and monitoring.

About FirstMark

FirstMark is a division of GenWay Biotech, Inc. The FirstMark division is focused on the development and commercialization of non-invasive diagnostic and health monitoring tests for unmet clinical needs. Headquarters are located in the heart of San Diego's biotech community in the Sorrento Valley/Mesa area. For additional information please visit FirstMarkPREvent.com.

Media Contact:

Deborah Moore GenWay Biotech, 858-458-0866, dmoore@genwaybio.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE FirstMark
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Improved Authentication and Confidentiality Protection. ICAP Patent Brokerage Announces for Auction Important Patents in Data Encryption and Document Security
2. ChromaDex® Announces Financial Results for the Year Ended 2011
3. Modern Mobility Aids, Inc. Announces a Revised Agreement for the Acquisition of Lumigene
4. Pew announces 2012 recipients of distinguished Marine Conservation Fellowship
5. PNAS announces 6 2011 Cozzarelli Prize recipients
6. ChromaDex® Announces Management Changes
7. Collaborative Health Consortium Announces eCollaboration Forum Final Agenda for HIMSS 2012
8. Medbox, Inc. Announces New Product Line for 2012
9. FASEB SRC announces conference registration open for: Virus Structure and Assembly
10. Elsevier announces publishing the Ocular Surface
11. Biophysical Society announces New and Notable Symposium speakers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2014)... have identified a new syndrome called "osteosarcopenic obesity" that ... with obesity. , "It used to be the thinking ... would be because the bones were supporting more weight," ... at Florida State. "But, that,s only true to a ...
(Date:4/16/2014)... Nicolas Doucet of the Centre INRSInstitut Armand-Frappier has just received ... in the amount of nearly US$600,000. The 5-year grant is ... called RNases and to explore their biomedical potential in the ... , "Receiving a grant at this level is ...
(Date:4/16/2014)... a densely packed array of finger-like projections called ... line our intestines., Vanderbilt University researchers have now discovered ... critical for absorbing nutrients and defending against pathogens. The ... , reveal a role for adhesion molecules in brush ...
Breaking Biology News(10 mins):Researchers: Obesity can amplify bone and muscle loss 2High-level NIH grant goes to professor Nicolas Doucet of INRS 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 3
... rodents known as Murinae (mice, rats, etc.), which first ... the entire Old World (Eurasia, Africa, Australia) in less ... have long suspected that one of the reasons for ... apparatus. Now, researchers have used the brilliant X-ray beams ...
... beginning of October. The goal is to develop the production ... manufacture tires made from dandelion rubber. This is why molecular ... supplier built a pilot facility in Mnster that is capable ... time, they cultivate several hectares of a dandelion variety which ...
... bus, escaping a burning building or taking part in ... up knee problems for later in life, according to ... Journal of Biomedical Engineering and Technology . 9 ... fatigue, numbness and bunions when wearing such footwear. Despite ...
Cached Biology News:Chewing their way to success 2Fraunhofer and Continental come together when the dandelion rubber meets the road 2Fraunhofer and Continental come together when the dandelion rubber meets the road 3No running for the well-heeled 2
(Date:1/15/2014)... Calif. (PRWEB) January 15, 2014 Cynvenio, ... and management through the genomic analysis of tumor cells ... Therapy Finder™, a web-based cancer decision support application powered ... option with Cynvenio’s ClearID™ genomic test, Therapy Finder will ...
(Date:1/15/2014)... , January 15, 2014 A study ... races on the Formula 1 track could help to tackle ... Applied Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) ... healthcare provider Simplyhealth. Telemetry technology, which is inspired ...
(Date:1/15/2014)... January 15, 2014 DTS Language Services, ... Online Web Portal for Life Science organizations who need document ... the subject matter of their documents in advance with a ... reduce time-to-delivery of translations, often a critical factor in clinical ...
(Date:1/15/2014)... TAIPEI , Jan. 15, 2014 TaiGen Biotechnology ... an exclusive agreement with R-Pharm, a leading Russian pharmaceutical ... in the Russian Federation , ... Commonwealth Independent States (CIS). Nemonoxacin is a novel antibiotic for ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... TIME: 8:30 a.m. Eastern Time HOST: Dr. Candace ... Kendle, Chairman and CEO, ... conference call and simultaneous webcast Oct. 31,at 8:30 a.m. Eastern Time to ... session will follow. (Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO ) Webcast Instructions ...
... Texas, Oct. 10 Luminex Corporation,(Nasdaq: LMNX ) ... on Wednesday, October 24, 2007. Results are scheduled for ... a conference call to discuss the operating,highlights and financial ... October 25, 2007, at 8:00 a.m. Eastern time. ...
... Campbell Alliance, the leading,management consulting firm specializing in ... was recognized as one of the best,places to work ... by the,Triangle Business Journal, ranking third among midsize companies. ... Business Journal,s annual Best,Places to Work luncheon and awards ...
Cached Biology Technology:Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast 2Luminex Corporation Third Quarter Earnings Release Scheduled for October 24, 2007 2Luminex Corporation Third Quarter Earnings Release Scheduled for October 24, 2007 3Campbell Alliance Named 'Best Place to Work' by Triangle Business Journal 2
... a high quality whole genome sequencing service. ... costs allow even the smallest of laboratories ... key features which set our whole genome ... construction strategies, proprietary assembly software, rapid project ...
Great for biotinylating DNA/RNA probes...
... polyclonal antibody to human XAB2 (amino terminus) ... identified through its interaction with XPA. Immunoprecipitation ... of XAB2 interacts with the transcription-coupled repair-specific ... with RNA polymerase II. Microinjection experiments with ...
... maintenance, calibration, and validation (MCV) ... 96-well plate used for hands-free ... procedures using the Bio-Plex suspension ... is for use with Bio-Plex ...
Biology Products: